
Sign up to save your podcasts
Or


Did you know that immunotherapy has shown promise in the perioperative setting for gastric and gastroesophageal junction (GEJ) adenocarcinoma?
Credit available for this activity expires: 7/11/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/transforming-gastric-and-gej-cancer-care-perioperative-2025a1000i7e?ecd=bdc_podcast_libsyn_mscpedu
By Medscape4.3
2525 ratings
Did you know that immunotherapy has shown promise in the perioperative setting for gastric and gastroesophageal junction (GEJ) adenocarcinoma?
Credit available for this activity expires: 7/11/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/transforming-gastric-and-gej-cancer-care-perioperative-2025a1000i7e?ecd=bdc_podcast_libsyn_mscpedu

136 Listeners

697 Listeners

498 Listeners

169 Listeners

106 Listeners

884 Listeners

14 Listeners

16 Listeners

296 Listeners

259 Listeners

3,341 Listeners

1,149 Listeners

193 Listeners

94 Listeners

512 Listeners

367 Listeners

172 Listeners

60 Listeners

8 Listeners

428 Listeners